Study of the periodontal disease prevalence and risk in SLE patients, and infulence of periodontal treatment

Study of the periodontal disease prevalence and risk in SLE patients, and infulence of periodontal treatment - Study of the periodontal disease prevalence and risk in SLE patients, and infulence of periodontal treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017008

Enrollment

Registered

2015-04-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

systemic lupus erythematosus

Interventions

periodontal treatment

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. SLE patients 2. PSL dose >= 20mg/day

Exclusion criteria

Exclusion criteria: Patients who have visited dentists for 6 months

Design outcomes

Primary

Measure	Time frame
SLEDAI in 24weeks	—

Countries

Japan

Contacts

Public ContactShuzo Yoshida

Osaka Medical College Rheumatology, Department of Internal Medicine 1

in1307@poh.osaka-med.ac.jp072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026